UB Paderborn / Katalog / Suche / in CDI

Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression

Circulation (New York, N.Y.), 2008-02, Vol.117 (6), p.732-742

2008

Link zum Volltext

Verfügbarkeit prüfen

The impact of rapid atrial pacing on ADMA and endothelial NOS

International journal of cardiology, 2012-01, Vol.154 (2), p.141-146

2012

Link zum Volltext

Verfügbarkeit prüfen

COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation

TH open : companion journal to thrombosis and haemostasis, 2020-07, Vol.4 (3), p.e271-e279

2020

Link zum Volltext

Verfügbarkeit prüfen

Kidney Diseases and NOAC therapy: Is there a light at the end of the tunnel?

International journal of cardiology, 2017-06, Vol.236, p.162-163

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical importance of atrial cardiomyopathy

International journal of cardiology, 2019-07, Vol.287, p.174-180

2019

Link zum Volltext

Verfügbarkeit prüfen

Atrial cardiomyopathy: Answer to Letter to the Editor by Dr. O. Jolobe

International journal of cardiology, 2019-08, Vol.288, p.101-101

2019

Link zum Volltext

Verfügbarkeit prüfen

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?

European heart journal supplements, 2020-12, Vol.22 (Suppl O), p.O28-O41

2020

Link zum Volltext

Verfügbarkeit prüfen

The safety of edoxaban for treating atrial fibrillation

Expert opinion on drug safety, 2017-11, Vol.16 (11), p.1295-1303

2017

Link zum Volltext

Verfügbarkeit prüfen

How important it is for therapy adherence to be once a day?

European heart journal supplements, 2016-12, Vol.18 (suppl I), p.I7-I12

2016

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?

Journal of cardiovascular pharmacology, 2015-12, Vol.66 (6), p.530-539

2015

Link zum Volltext

Verfügbarkeit prüfen

Upstream-Therapie bei Vorhofflimmern

Herzschrittmachertherapie & Elektrophysiologie, 2014, Vol.25 (1), p.33-40

2014

Link zum Volltext

Verfügbarkeit prüfen

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management

Clinical research in cardiology, 2019-06, Vol.108 (6), p.577-599

2019

Link zum Volltext

Verfügbarkeit prüfen

Successful catheter ablation of a left posterolateral accessory bypass tract and periinterventional management in a patient with MELAS syndrome

Herzschrittmachertherapie & Elektrophysiologie, 2022-09, Vol.33 (3), p.330-333

2022

Link zum Volltext

Verfügbarkeit prüfen

Upstream therapy for atrial fibrillation

Herzschrittmachertherapie & Elektrophysiologie, 2014-03, Vol.25 (1), p.33-40

2014

Link zum Volltext

Verfügbarkeit prüfen

Rhythmogenic syncopes and survived sudden cardiac death

Herzschrittmachertherapie & Elektrophysiologie, 2019-03, Vol.30 (1), p.72-88

2019

Link zum Volltext

Verfügbarkeit prüfen

Atrial thrombogenesis in atrial fibrillation: Results from atrial fibrillation models and AF-patients

Herzschrittmachertherapie & Elektrophysiologie, 2018-03, Vol.29 (1), p.76-83

2018

Link zum Volltext

Verfügbarkeit prüfen

Platelet Expression of CD40/CD40 Ligand and Its Relation to Inflammatory Markers and Adhesion Molecules in Patients with Atrial Fibrillation

Experimental biology and medicine (Maywood, N.J.), 2007-04, Vol.232 (4), p.581-589

2007

Link zum Volltext

Verfügbarkeit prüfen

ENZYMATIC ACTIVITY OF DPIV AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) PROTEASES AS PREDICTORS FOR APPROPRIATE ICD INTERVENTION IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E78-E78

2011

Link zum Volltext

Verfügbarkeit prüfen

Induction of ventricular tachycardia during radiofrequency ablation via pulmonary vein ablation catheter in a patient with an implanted pacemaker

Europace (London, England), 2012-02, Vol.14 (2), p.298-299

2012

Link zum Volltext

Verfügbarkeit prüfen

Will Warfarin Soon Be Passé? New Approaches to Stroke Prevention in Atrial Fibrillation

Journal of cardiovascular pharmacology, 2008-07, Vol.52 (1), p.18-27

2008

Link zum Volltext

Verfügbarkeit prüfen

Upstream therapy for atrial fibrillation

Herzschrittmachertherapie & Elektrophysiologie, 2014-03, Vol.25 (1), p.33

2014

Link zum Volltext

Verfügbarkeit prüfen

Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD)

International journal of cardiology, 2013-09, Vol.168 (1), p.255-260

2013

Link zum Volltext

Verfügbarkeit prüfen

Inadvertend catch of a factor VIII rich thrombus with a femoral sheath during cardiac catheterization

International journal of cardiology, 2008-10, Vol.130 (1), p.e39-e41

2008

Link zum Volltext

Verfügbarkeit prüfen

Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation

Cardiovascular pathology, 2010-05, Vol.19 (3), p.e51-e60

2010

Link zum Volltext

Verfügbarkeit prüfen

New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation

Current vascular pharmacology, 2007-07, Vol.5 (3), p.211

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression

The impact of rapid atrial pacing on ADMA and endothelial NOS

COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation

Kidney Diseases and NOAC therapy: Is there a light at the end of the tunnel?

Clinical importance of atrial cardiomyopathy

Atrial cardiomyopathy: Answer to Letter to the Editor by Dr. O. Jolobe

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?

The safety of edoxaban for treating atrial fibrillation

How important it is for therapy adherence to be once a day?

The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?

Upstream-Therapie bei Vorhofflimmern

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management

Successful catheter ablation of a left posterolateral accessory bypass tract and periinterventional management in a patient with MELAS syndrome

Upstream therapy for atrial fibrillation

Rhythmogenic syncopes and survived sudden cardiac death

Atrial thrombogenesis in atrial fibrillation: Results from atrial fibrillation models and AF-patients

Platelet Expression of CD40/CD40 Ligand and Its Relation to Inflammatory Markers and Adhesion Molecules in Patients with Atrial Fibrillation

ENZYMATIC ACTIVITY OF DPIV AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) PROTEASES AS PREDICTORS FOR APPROPRIATE ICD INTERVENTION IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION

Induction of ventricular tachycardia during radiofrequency ablation via pulmonary vein ablation catheter in a patient with an implanted pacemaker

Will Warfarin Soon Be Passé? New Approaches to Stroke Prevention in Atrial Fibrillation

Upstream therapy for atrial fibrillation

Enzymatic activity of DPIV and renin–angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD)

Inadvertend catch of a factor VIII rich thrombus with a femoral sheath during cardiac catheterization

Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation

New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation

Suchergebnisse filtern